DrugJan 3, 2024
Sertraline Tablets, USP 100 mg, 30 tablets per bottle recall — FDA D-0205-2024
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
Class IIFDA: OngoingLegacy Pharmaceutical Packaging LLC
Recall history in this database
Classification mix: Class II: 1.
Understanding this recall history
This page summarizes recall records in which the official source identifies Legacy Pharmaceutical Packaging LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.